GrowGeneration

GRWG

Market cap $67.3M

The ancillary cannabis sector continues to gain attention in April 2026. These companies support the industry without touching the plant. As a result, they avoid many regulatory risks associated with federal law. Meanwhile, the U.S. cannabis market keeps expanding rapidly. Industry sales have already surpassed $30 billion annually and continue growing.

The cannabis industry has been growing at a fast pace, and the world is taking notice. In just the US alone, the boom of the legal cannabis business has exploded. Everything from over-the-counter CBD products to THC at your local dispensary. Between the recreational and medical markets, the amount of revenue generated is in the billions. This has sparked the interest of many individuals seeking the best investment opportunities.

GrowGeneration Corp. (GRWG) Q4 2025 Earnings Call Transcript

Full Year Net Sales of $161.7 million including Proprietary Brand Sales of $44.0 million Full Year Proprietary Brand Penetration Increased to 32.8% up from 24.2% in the prior year Full Year GAAP Net Loss Improved by $25.5 million; Adjusted EBITDA Improved by $8.5 million $46.1 million of Cash and Marketable Securities and no debt Board Authorizes $10 Million Share Repurchase Program 2026 Outlook: Revenue of $162 million to $168 million and Breakeven Adjusted EBITDA(1) DENVER, March 19, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG), (“GrowGeneration,” “GrowGen” or the “Company”), one of the nation's largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and garden centers, today announced financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Summary(1) Net sales of $37.8 million, compared to prior year net sales of $37.4 million, an improvement of 1.0%; Proprietary brand sales as a percentage of Cultivation and Gardening net sales increased to 35.8%, compared to 30.4% in the prior year; Gross profit margin of 24.1%, compared to 16.4% in the prior year; Store and other operating expenses declined approximately 26.8% to $6.8 million, compared to $9.3 million for the same period in the prior year; Total operating expenses decreased $13.3 million, or 44.4%, to $16.7 million in the fourth quarter of 2025, compared to $30.1 million in the prior year; Net loss improved to $7.4 million, compared to a net loss of $23.3 million in the prior year which includes non-cash impairments; and Adjusted EBITDA(3) loss of $2.0 million compared to a loss of $8.1 million in the prior year.

The momentum is building once again for marijuana stocks. Since the passing of rescheduling cannabis to class 3, investors are staying sharp. Even though this does not legalize cannabis federally, it brings more relaxed investing without stressing federal issues. The cannabis industry has been undergoing another shift due to this. At the same time, this has led more people to find the best marijuana stocks to buy and hold till the market is up.

The U.S. cannabis industry continues expanding despite periods of volatility across the sector. However, ancillary cannabis companies remain essential to the industry's infrastructure. These businesses supply equipment, nutrients, lighting, and hydroponic systems to cannabis cultivators. Because they do not touch the cannabis plant directly, ancillary companies often face fewer regulatory restrictions.

DENVER, March 05, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), one of the nation's largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, March 19, 2026, after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET.

Even with legal cannabis growing in acceptance, it is still a highly volatile market. This means that most publicly traded cannabis companies exhibit unpredictable trading patterns. Now, all sectors of the stock market face volatility; it's just that the cannabis sector sees a significant portion of it. However, volatility has not stopped investors from making a profit.

Marijuana stocks are still facing a battle in the stock market. The cannabis sector has been fighting to reach higher trading levels more consistently. For some time, there has been significant volatility that has been somewhat challenging for shareholders. You would think that with legal operators showing profitability and overall success, it would follow for the public sector. However, this has not been the case in most instances.

The cannabis sector continues to evolve as 2026 begins. While plant-touching operators still face regulatory pressure, ancillary companies remain better positioned. These businesses do not grow or sell cannabis directly. Instead, they provide the tools, products, and infrastructure that the industry depends on. As a result, they often carry less regulatory risk. They also tend to survive market downturns more effectively.